ABOS - Acumen Pharmaceuticals EPS beats by $0.07 November, 15 2021 09:03 AM Acumen Pharmaceuticals Inc. Acumen Pharmaceuticals (NASDAQ:ABOS): Q3 GAAP EPS of -$0.10 beats by $0.07. Cash equivalents and marketable securities of $199.96M Press Release For further details see: Acumen Pharmaceuticals EPS beats by $0.07